Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Ji

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Cancer Science|June 22, 2010
Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapyHongbin Ji
Protein & Cell|March 8, 2011
LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressorYijun Gao, Gaoxiang Ge, Hongbin Ji
Cancer Metastasis Reviews|November 29, 2025
Advancing small cell lung cancer metastasis research: innovations in preclinical mouse modelsQiqi Zhao, Liang Hu, Hongbin Ji
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 18, 2024
TIL Therapy in Lung Cancer: Current Progress and PerspectivesWeilei Hu, Yifei Bian, Hongbin Ji
Life Metabolism|January 28, 2025
MRE11 lactylation: a linker between Warburg effect and DNA repairPingyu Liu, Hongbin Ji, Fuming Li
Cell Research|September 7, 2011
A network-based gene-weighting approach for pathway analysisZhaoyuan Fang, Weidong Tian, Hongbin Ji
Trends in Cancer|July 26, 2017
Squamous Transition of Lung Adenocarcinoma and Drug ResistanceShenda Hou, Xiangkun Han, Hongbin Ji
Cancer Research|March 24, 2025
"Dr. Jekyll and Mr. Hyde": AT2 Cells in Lung Regeneration and Tumor DevelopmentXinyuan Tong, Gen Lin, Hongbin Ji
Protein & Cell|October 21, 2016
Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistanceYingjiao Xue, Shenda Hou, Hongbin Ji, et al.
Cell Cycle (Georgetown, Tex.)|September 14, 2006
EGFR targeted therapy: view from biological standpointHongbin Ji, Norman E Sharpless, Kwok-Kin Wong
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Cancer Science|June 22, 2010
Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapyHongbin Ji
Protein & Cell|March 8, 2011
LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressorYijun Gao, Gaoxiang Ge, Hongbin Ji
Cancer Metastasis Reviews|November 29, 2025
Advancing small cell lung cancer metastasis research: innovations in preclinical mouse modelsQiqi Zhao, Liang Hu, Hongbin Ji
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 18, 2024
TIL Therapy in Lung Cancer: Current Progress and PerspectivesWeilei Hu, Yifei Bian, Hongbin Ji
Life Metabolism|January 28, 2025
MRE11 lactylation: a linker between Warburg effect and DNA repairPingyu Liu, Hongbin Ji, Fuming Li
Cell Research|September 7, 2011
A network-based gene-weighting approach for pathway analysisZhaoyuan Fang, Weidong Tian, Hongbin Ji
Trends in Cancer|July 26, 2017
Squamous Transition of Lung Adenocarcinoma and Drug ResistanceShenda Hou, Xiangkun Han, Hongbin Ji
Cancer Research|March 24, 2025
"Dr. Jekyll and Mr. Hyde": AT2 Cells in Lung Regeneration and Tumor DevelopmentXinyuan Tong, Gen Lin, Hongbin Ji
Protein & Cell|October 21, 2016
Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistanceYingjiao Xue, Shenda Hou, Hongbin Ji, et al.
Cell Cycle (Georgetown, Tex.)|September 14, 2006
EGFR targeted therapy: view from biological standpointHongbin Ji, Norman E Sharpless, Kwok-Kin Wong
Pageof 22